BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15626733)

  • 1. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage.
    Salomoni P; Bernardi R; Bergmann S; Changou A; Tuttle S; Pandolfi PP
    Blood; 2005 May; 105(9):3686-90. PubMed ID: 15626733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The function of PML in p53-dependent apoptosis.
    Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi PP
    Nat Cell Biol; 2000 Oct; 2(10):730-6. PubMed ID: 11025664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.
    Louria-Hayon I; Grossman T; Sionov RV; Alsheich O; Pandolfi PP; Haupt Y
    J Biol Chem; 2003 Aug; 278(35):33134-41. PubMed ID: 12810724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
    Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
    J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.
    Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi PP
    J Exp Med; 2000 Feb; 191(4):631-40. PubMed ID: 10684855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
    Song H; Boo JH; Kim KH; Kim C; Kim YE; Ahn JH; Jeon GS; Ryu H; Kang DE; Mook-Jung I
    Cell Death Differ; 2013 Apr; 20(4):639-48. PubMed ID: 23306558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase.
    Shin J; Park B; Cho S; Lee S; Kim Y; Lee SO; Cho K; Lee S; Jin BS; Ahn JH; Choi EJ; Ahn K
    J Biol Chem; 2004 Sep; 279(39):40994-1003. PubMed ID: 15273249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cytoplasmic PML mutant inhibits p53 function.
    Bellodi C; Kindle K; Bernassola F; Cossarizza A; Dinsdale D; Melino G; Heery D; Salomoni P
    Cell Cycle; 2006 Nov; 5(22):2688-92. PubMed ID: 17172828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML.
    Seker H; Rubbi C; Linke SP; Bowman ED; Garfield S; Hansen L; Borden KL; Milner J; Harris CC
    Oncogene; 2003 Mar; 22(11):1620-8. PubMed ID: 12642865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.
    Yang S; Kuo C; Bisi JE; Kim MK
    Nat Cell Biol; 2002 Nov; 4(11):865-70. PubMed ID: 12402044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PML and the PML-nuclear body in the control of programmed cell death.
    Bernardi R; Pandolfi PP
    Oncogene; 2003 Dec; 22(56):9048-57. PubMed ID: 14663483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body language: the function of PML nuclear bodies in apoptosis regulation.
    Hofmann TG; Will H
    Cell Death Differ; 2003 Dec; 10(12):1290-9. PubMed ID: 12934066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.
    Wu WS; Xu ZX; Hittelman WN; Salomoni P; Pandolfi PP; Chang KS
    J Biol Chem; 2003 Apr; 278(14):12294-304. PubMed ID: 12540841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.
    Crowder C; Dahle Ø; Davis RE; Gabrielsen OS; Rudikoff S
    Blood; 2005 Feb; 105(3):1280-7. PubMed ID: 15459016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SUMO-1-modified PML in nuclear body formation.
    Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
    Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.